Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat
- 2 August 2003
- journal article
- Published by Elsevier in Life Sciences
- Vol. 73 (18) , 2345-2353
- https://doi.org/10.1016/s0024-3205(03)00651-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Messenger plasticity in primary sensory neurons following axotomy and its functional implicationsPublished by Elsevier ,2003
- CB cannabinoid receptor agonists: pain relief without psychoactive effects?Current Opinion in Pharmacology, 2002
- The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic painPublished by Wolters Kluwer Health ,2001
- Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamideEuropean Journal of Pharmacology, 2001
- Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid receptorsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1999
- Change in mRNAs for neuropeptides and the GABAA receptor in dorsal root ganglion neurons in a rat experimental neuropathic pain modelPain, 1998
- Control of pain initiation by endogenous cannabinoidsNature, 1998
- The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory painPain, 1998
- The capsaicin receptor: a heat-activated ion channel in the pain pathwayNature, 1997
- N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activationEuropean Journal of Pharmacology, 1996